OMER, GLBE and QURE are among after hour movers
Gainers: Global-E Online  (GLBE) +4%. NETGEAR (<a href="https://seekingal...
Seekingalpha · 4d ago
TOPS, CANO and SPRO are among pre market gainers
Top Ships (TOPS) +45%. Flux Power Holdings (<a href="https://seekingalph...
Seekingalpha · 09/23 12:26
Spero, HeartBeam top healthcare gainers; MediWound, Vincerx lead losers' pack
Gainers: Spero Therapeutics SPRO +135%. HeartBeam (BEAT) <font co...
Seekingalpha · 09/22 14:03
Spero Therapeutics (SPRO) Soars 137% on Exclusive License Agreement
Investor Place · 09/22 13:56
Spero stock soars 79% as GSK to pick stake under license deal for UTI antibiotic
GSK (NYSE:GSK) is <a href="
Seekingalpha · 09/22 08:55
Terns, IVERIC top healthcare gainers; Alector, LifeStance lead losers' pack
Gainers: Terns Pharmaceuticals (TERN) +18%. IVERIC bi...
Seekingalpha · 09/09 14:02
PTN, ERAS and Merc among mid-day movers
Gainers: ShiftPixy (PIXY) +105%. Amylyx Pharmaceuticals (<a ...
Seekingalpha · 09/08 16:54
Bilibili, Wayfair, American Eagle Outfitters among premarket losers' pack
American Eagle Outfitters AEO -12% on <a href="" targ...
Seekingalpha · 09/08 12:14
Can Justin Herbert Help SOFI Stock Score a Touchdown?
Investor Place · 09/07 15:22
Spero (SPRO) Up Following Positive FDA Update for UTI Drug
Spero (SPRO) surges on achieving common ground with the FDA on the regulatory path forward for tebipenem HBr.
Zacks · 09/07 14:36
Why Is Spero Therapeutics (SPRO) Stock Up 15% Today?
Investor Place · 09/07 14:34
Spero Therapeutics to Present at Upcoming Investor Conference
CAMBRIDGE, Mass., Sept. 07, 2022 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing treatments in high unmet need areas involving rare d...
GlobeNewswire · 09/07 12:05
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Investor Place · 09/07 11:27
Spero Therapeutics Provides Tebipenem HBr Program Update Following Type A Meeting with the U.S. Food and Drug Administration
Alignment with the FDA on a regulatory path forward for the continued development of tebipenem Hbr FDA feedback indicates positive results from a single additional Phase 3 clinical trial in patients with complicated urinary tract infection (cUTI), with sup...
GlobeNewswire · 09/06 12:05
Can Spero Therapeutics (NASDAQ:SPRO) Afford To Invest In Growth?
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although
Simply Wall St. · 09/05 10:49
Spero Therapeutics, Inc. (SPRO) Reports Q2 Loss, Misses Revenue Estimates
Spero Therapeutics, Inc. (SPRO) delivered earnings and revenue surprises of 1.14% and 13.35%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 08/10 21:25
Spero Therapeutics GAAP EPS of -$0.87, revenue of $1.99M
Spero Therapeutics press release (<span class="tick...
Seekingalpha · 08/10 20:50
-- Earnings Flash (SPRO) SPERO THERAPEUTICS Posts Q2 Revenue $2M
-- Earnings Flash (SPRO) SPERO THERAPEUTICS Posts Q2 Revenue $2M
MT Newswires · 08/10 16:25
Spero Therapeutics to Provide Business Update and Report Second Quarter 2022 Financial Results on Wednesday, August 10, 2022
CAMBRIDGE, Mass., Aug. 09, 2022 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO) today announced that it will host a conference call and live audio webcast on Wednesday, August 10, 2022 at 4:30 p.m. ET to report its second quarter 2022 financial...
GlobeNewswire · 08/09 12:05
The Women Who Shaped Short-Term Rental History
The dudes got all the headlines and — let’s face it — because of ingrained sexism and the traditional old boys’ networks, they took an inordinate share of the top jobs, but there were many talented women leaders and entrepreneurs who likewise shaped the hi...
Skift · 07/06 06:30
Webull provides a variety of real-time SPRO stock news. You can receive the latest news about CBOE S&P500 Bufr Prtct Indx Blnc Series through multiple platforms. This information may help you make smarter investment decisions.